Journal
CLINICAL NUCLEAR MEDICINE
Volume 43, Issue 4, Pages 276-278Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/RLU.0000000000002001
Keywords
penile metastasis; prostate cancer; Ga-68-PSMA PET; CT; Lu-177-PSMA radioligand therapy
Ask authors/readers for more resources
An 85-year-old man with prostate cancer for metastatic workup underwent (68)Gallium Prostate-Specific Membrane Antigen (Ga-68-PSMA) PET/CT (Ga-68-PSMA PET/CT), which revealed unusual tracer uptake in the shaft and glans of penis as well as multiple systemic metastases in liver, skeletal, and lymph nodes. The penile lesion was proved to be metastatic adenocarcinoma from prostate on fine needle aspiration cytology. The patient underwent (177)Lutetium (Lu-177)-labeled PSMA radioligand therapy, which also revealed diffuse tracer uptake in the penile shaft as well as other metastatic sites.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available